Guidelines and registries: secondary prophylaxis after AMI with emphasis on the use of beta-blockers and ACE inhibitors.
Otterstad
Jan Erik
JE
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D009664:Norway; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000592:standards; D011379:Prognosis; D012042:Registries; D018570:Risk Assessment; D055502:Secondary Prevention; D015996:Survival Rate; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors